Clinical Trials

Pancreatic and lung cancer clinical trials are currently open for patient enrollment at Vita Medical Associates, P.C.

Tumor Treating Fields (TTFields) is a non-invasive regional treatment, which has been demonstrated to prolong survival in a Phase 3 study in newly diagnosed glioblastoma. In 2019, the FDA approved the NovoTTF-100L™ System in combination with chemotherapy for the treatment of malignant pleural Mesothelioma.

The TTFields device is currently being tested in combination with standard of care chemotherapy in clinical trials for locally advanced pancreatic adenocarcinoma and stage 4 non-small cell lung cancer.

NovoCure Panova-3 Pancreatic Cancer Study

panova 3

NovoCure Lunar Lung Cancer Study

novocure lung study



Request An Appointment

  • This field is for validation purposes and should be left unchanged.

Vita Medical Associates

306 S. New Street, Suite 201
Bethlehem, PA 18015
Tel: 610-866-0113
Fax: 610-974-8589

Scroll to Top